- 90,000 sq. ft. of ISO 8 clean room for production of Insulet’s leading Omnipod medical device
- Fast-track construction requiring $8 million of work to be put in place each month
- Integration of a new central utility plant in the existing building that is capable of servicing the new campus
Insulet Corporation, the leader in tubeless insulin pump technology (Omnipods), acquired a property in Acton, MA to serve as its sole U.S.-based manufacturing location. The new facility provides capacity for Insulet to manufacture up to 70% more Omnipods on a single line with up to 90% fewer personnel than its four locations based in China.
The existing 201,690 sq. ft., three-story building was converted to a high-end corporate and manufacturing campus featuring space for research and development, post-market research and quality control operations, a call center, an employee fitness center with locker rooms, a 7,492 sq. ft. cafeteria and commercial kitchen as well as open offices, conference rooms and executive suites. The 155,252 sq. ft. addition, provides clean room manufacturing and warehouse space, quarantine inspection and receiving areas, a gowning and wash unit, packaging rooms and a shipping/receiving area. Work was completed on a fast-track schedule and utilize Lean practices to attain a quick, collaborative start. During construction, the Consigli team pre-fabricated key project elements including the addition’s façade and M/E/P racks to accelerate the schedule and remove labor from the site. The second phase of the project includes the construction of a four-level, 600-space parking garage to accommodate the significant influx of Insulet employees to campus.